Our top 10 ALS news stories of 2025 feature actor Eric Dane’s advocacy and major research milestones in the field.
Actor Eric Dane, who lives with ALS, has joined the board of directors of the U.S. nonprofit Target ALS, with an aim of ...
MyoRegulator, a device to be used at home to slow disability progression in ALS, has been granted breakthrough device ...
NUZ-001, an investigational oral therapy for ALS, is officially the ninth compound to be included in the HEALEY ALS platform ...
FDA cleared the start of a pivotal Phase 3 trial testing pridopidine, an oral therapy for ALS. The study will enroll people with early, rapidly progressive ALS. Earlier subgroup analyses suggested ...
Qalsody, a gene-targeted therapy for SOD1-ALS, is nearing public funding in Canada. It reduces toxic SOD1 protein, which is expected to slow ALS progression. Reimbursement is contingent on a price ...
New method uses blood genetic activity, machine learning to detect ALS, predict survival. A 46-gene panel accurately IDs ALS, showing promise for improving diagnosis. Analysis identifies potential ALS ...
A bipartisan team of congressional representatives is pushing for new legislation that aims to understand why veterans are at increased… ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback